Epigral Ltd. Financials: Quarterly Results
Revenue
602.68
Cr.
PAT
39.15
Cr.
EBITDA
65.55
Cr.
Epigral Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 597.12 | 587.36 | 606.54 | 627.63 | 645.24 |
| Total Income From Operations (Cr.) | 597.12 | 587.36 | 606.54 | 627.63 | 645.24 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 65.55 | 91.79 | 130.10 | 142.83 | 153.46 |
| P/L Before Exceptional Items & Tax (Cr.) | 54.60 | 69.95 | 106.73 | 131.06 | 153.53 |
| P/L After Tax from Ordinary Activities (Cr.) | 39.15 | 51.52 | 160.41 | 86.62 | 103.54 |
| Net Profit/Loss For the Period (Cr.) | 39.15 | 51.52 | 160.41 | 86.62 | 103.54 |
| Basic EPS | 9.07 | 11.87 | 37.25 | 20.14 | 24.25 |
FAQs
Epigral Ltd. announced its quarterly results for Q3 FY2026 on January 30, 2026.
In Q3 FY2026, Epigral Ltd. are as follows:
Revenue: ₹602.68 crore
Net Profit: ₹39.15 crore.
For Q3 FY2026, Epigral Ltd. posted ₹602.68 crore in revenue and ₹39.15 crore in net profit.
Past quarterly results for Epigral Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.